Loading company…
Santa Maria Biotherapeutics develops therapies for cachexia associated with ovarian cancer.
Founded in 2012 in California, Santa Maria Biotherapeutics develops therapies intended to mitigate cachexia in the treatment of ovarian cancer.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in